Autumn/Winter 23/24

Here we would like to provide you with up-to-date information and surveys from the RESPINOW project and other sources that allow the epidemiological situation and possible development with regard to the dynamics and disease burden of RSV, influenza and pneumococci. This is essentially information and classifications from the following sources of information:

Population-based estimates of ARE, ILI and
Frequency of infections due to SARS-CoV-2, influenza and RSV

Within the framework of TP2 RESPINOW, the EU project PCR-4-ALL, the ZIFCO project and the MuSPAD study of the Helmholtz Association, about 2000 people are performing rapid tests for the aforementioned pathogens on a regular basis and when symptoms occur. This helps us to assess both how many people are currently experiencing respiratory symptoms and which pathogens are causing them.

This information is then compared with publicly available data on the frequency of these pathogens in people who go to the doctor(

Short-term predictions of dynamics and disease burden
of SARS-CoV-2, Influenza, RSV and Pneumococcus.

As part of TP4 of RESPINOW, a Forecasting Hub for RSV, Influenza and Pneumococcus is being established, to which several of the RESPINOW groups are also contributing modeling.

As part of a European initiative, we also contribute short-term forecasts to the ECDC Forecasting Hub.

Further, we are active as one of the groups of MONID contributing scenario modeling in the current round of modeling.

Of course, there are many other important sources of information that we also use to keep up to date on the current epidemic situation of respiratory infections. We would like to mention in particular respiratory surveillance, which is carried out at the RKI, and surveillance of treatment capacity: